It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Human centromeres appear as constrictions on mitotic chromosomes and form a platform for kinetochore assembly in mitosis. Biophysical experiments led to a suggestion that repetitive DNA at centromeric regions form a compact scaffold necessary for function, but this was revised when neocentromeres were discovered on non-repetitive DNA. To test whether centromeres have a special chromatin structure we have analysed the architecture of a neocentromere. Centromere repositioning is accompanied by RNA polymerase II recruitment and active transcription to form a decompacted, negatively supercoiled domain enriched in ‘open’ chromatin fibres. In contrast, centromerisation causes a spreading of repressive epigenetic marks to surrounding regions, delimited by H3K27me3 polycomb boundaries and divergent genes. This flanking domain is transcriptionally silent and partially remodelled to form ‘compact’ chromatin, similar to satellite-containing DNA sequences, and exhibits genomic instability. We suggest transcription disrupts chromatin to provide a foundation for kinetochore formation whilst compact pericentromeric heterochromatin generates mechanical rigidity.
In this study, using a human neocentromere as a model, the authors show that centromeres have a special chromatin structure. Centromere repositioning triggers transcriptional activation, epigenetic remodelling and chromatin fibre decompaction.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details


1 The University of Edinburgh, MRC Human Genetics Unit, Edinburgh, UK (GRID:grid.4305.2) (ISNI:0000 0004 1936 7988)
2 The University of Edinburgh, MRC Human Genetics Unit, Edinburgh, UK (GRID:grid.4305.2) (ISNI:0000 0004 1936 7988); University of Bari, Department of Biology, Bari, Italy (GRID:grid.7644.1) (ISNI:0000 0001 0120 3326)
3 The University of Edinburgh, MRC Human Genetics Unit, Edinburgh, UK (GRID:grid.4305.2) (ISNI:0000 0004 1936 7988); University of Bologna, Department of Pharmacy and Biotechnology, Bologna, Italy (GRID:grid.6292.f) (ISNI:0000 0004 1757 1758)
4 University of Bari, Department of Biology, Bari, Italy (GRID:grid.7644.1) (ISNI:0000 0001 0120 3326)